GKIM
PLXP

GW&K Investment Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

GW&K Investment Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-424,921
Closed -$1.03M – 843
2022
Q2 		$1.03M Sell
424,921
-3,250
-0.8% -$9.03K 0.01% 323
2022
Q1 		$1.73M Sell
428,171
-4,700
-1% -$25.8K 0.02% 317
2021
Q4 		$3.47M Sell
432,871
-23,725
-5% -$278K 0.03% 292
2021
Q3 		$8.81M Buy
456,596
+2,675
+0.6% +$46.7K 0.08% 222
2021
Q2 		$6.26M Hold
453,921
– – 0.05% 256
2021
Q1 		$4.1M Buy
+453,921
New +$3.32M 0.04% 293

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

GW&K Investment Management's PLXP Position: Q3 2022 in Review

GW&K Investment Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2022, closing a stake of 424,921 shares — an estimated $1.03M sold.

GW&K Investment Management first reported a position in PLXP in Q1 2021 and held it in 6 quarters. The position peaked at $8.81M in Q3 2021. 40 funds tracked by Wall St. Rank hold PLXP as of Q3 2022.

  • GW&K Investment Management reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • GW&K Investment Management sold 424,921 PLx Pharma Inc. Common Stock shares in Q3 2022, an estimated $1.03M.
  • GW&K Investment Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • GW&K Investment Management's PLx Pharma Inc. Common Stock position peaked at $8.81M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2022.

Based on GW&K Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.